TRU-SENTIMENT ยท DeltaNeutral
TEM Trading Analysis - 11/20/2026 04:17 PM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
TEM (Tempus AI Inc. Class A Common Stock) at $54.08. True Sentiment Bearish, delta 40-60 call 23% / put 77%, call $1,433,245 vs put $4,797,422. RSI 38.5.
- Symbol
- TEM
- Price
- $54.08
- Article bias (separate from True Sentiment)
- bearish
- Conviction
- medium
- Published
- 2026-11-20 16:17:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)From the True Sentiment options file (methodology: Delta 40-60 only, 98 of 1088 analyzed, filter 9.0%):
Call Volume: $1,433,245.00 (23.0%) Put Volume: $4,797,422.00 (77.0%) Total: $6,230,667.00
Call contracts 2,384 vs put contracts 8,607; call trades 50 vs put trades 48. Sentiment is flagged Bearish. The pure directional put-dollar dominance (3.3x call dollar volume) signals strong conviction to the downside into the next major expiry. This aligns with the bearish technical stack and weak daily momentum; no divergence is present between sentiment and price trend.
Key Statistics: TEM
Fundamental Snapshot
Valuation
| P/E (trailing) | 39.30 |
| EPS (trailing 12 mo) | $-1.06 |
| Market cap | $9.80B |
| Shares outstanding | 182.4M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| 52-week low | $40.77 |
| 52-week high | $89.09 |
| Historical volatility | 87.3% |
Ownership & trading
| Institutional ownership | 39.6% |
| Average daily volume | 6.5M sh |
Reported figures; no analyst estimates.
๐ Analysis
News Headlines & Context
The following items are based on general knowledge and are separated from the data-driven analysis below.
- Tempus AI (TEM) reported third-quarter 2026 results earlier in November, highlighting expanded hospital partnerships but continued net losses per share.
- Recent sector rotation out of high-valuation AI names has pressured small-to-mid cap healthcare tech stocks including TEM.
- Analysts have debated TEM's path to profitability amid rising competition in diagnostics AI and unclear reimbursement timelines.
- No confirmed major catalyst such as FDA clearance or M&A announcement has surfaced in the last two weeks per general knowledge.
Context: The general softness in AI-linked healthcare equities aligns with the embedded technical and options data showing a sharp November drawdown and bearish directional options flow.
Fundamental Analysis
Based strictly on the provided FUNDAMENTALS data (source: FinWin fundamentals local):
- Trailing P/E is 39.30; however trailing EPS is negative at -1.06, indicating the company is not currently profitable.
- Market capitalization is $9,802,283,480.00 with shares outstanding of 182,402,000.00.
- Dividend yield is 0.00% with no dividend rate or ex-dividend date provided.
- Institutional ownership is 39.60% of shares.
- 52-week high is $89.09 and 52-week low is $40.77; current technical price near $60.06 sits below the midpoint of that range.
- Historical volatility is 87.30%, reflecting an elevated risk profile.
- Average volume is 6,542,000.00 shares.
- PEG ratio, forward P/E, forward EPS, profit margins, ROE, debt/equity, and free cash flow are all null โ not available in the data.
- Analyst consensus, target mean price, and number of opinions are null โ no analyst target context provided.
Fundamental alignment: The negative EPS and undefined margin/return metrics contrast with a positive trailing P/E that is mechanically distorted by losses. This weak profitability context is consistent with the bearish technical and options-flow picture rather than diverging from it.
Current Market Position
From the embedded data, the daily close on 2026-11-19 was $60.06. The minute bars show the stock opened 2026-11-19 at $64.63, traded as high as $66.08 and as low as $59.41 that day, and by the final minute bar on 2026-11-20 at 15:45 closed at $54.08 after dipping to $53.26 earlier in the session.
Intraday momentum on 2026-11-20 was weak: the last five minute bars declined from $53.94 open to $53.26 low before a minor bounce to $54.08 on elevated final-bar volume of 168,293. The 154 total minute bars capture a two-session slide from mid-$60s to mid-$50s.
Technical Analysis
Technical Indicators
Price is below all three SMAs (5/20/50), with the 5-day at $64.66 under the 20- and 50-day (~$72.82/$72.93), confirming a bearish aligned stack and no bullish crossover. RSI at 38.50 shows weak momentum but not yet oversold (<30). MACD line -1.74 is below signal -1.39 with negative histogram -0.35, indicating continuing bearish momentum. Bollinger Bands show price pressing the lower band ($59.76) after trading mid-range previously โ an expansion lower, not a squeeze. The 30-day range high is $85.75 and low is $59.41; price at $60.06 is near the very bottom 3% of that range.
True Sentiment Analysis (Delta 40-60 Options)
From the True Sentiment options file (methodology: Delta 40-60 only, 98 of 1088 analyzed, filter 9.0%):
Call Volume: $1,433,245.00 (23.0%) Put Volume: $4,797,422.00 (77.0%) Total: $6,230,667.00
Call contracts 2,384 vs put contracts 8,607; call trades 50 vs put trades 48. Sentiment is flagged Bearish. The pure directional put-dollar dominance (3.3x call dollar volume) signals strong conviction to the downside into the next major expiry. This aligns with the bearish technical stack and weak daily momentum; no divergence is present between sentiment and price trend.
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.